Comment on "In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma"

Walter González; Jean-Marc Idée; Sebastien Ballet

doi:10.1021/acs.molpharmaceut.7b00138

Comment on "In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma"

Mol Pharm. 2018 Jan 2;15(1):332-335. doi: 10.1021/acs.molpharmaceut.7b00138. Epub 2017 Dec 1.

Authors

Walter González¹, Jean-Marc Idée¹, Sebastien Ballet²

Affiliations

¹ Research Department, Guerbet , 95943 Roissy CDG, France.
² Medical Affairs Department, Guerbet , 95943 Roissy CDG, France.

PMID: 29193977
DOI: 10.1021/acs.molpharmaceut.7b00138

No abstract available

Keywords: Lipiodol; conventional transarterial chemoembolization (c-TACE); doxorubicin; doxorubicinol; drug-eluting beads; hepatocellular carcinoma; interventional radiology; liver cancer; local therapy.

Publication types

Comment

MeSH terms

Antibiotics, Antineoplastic
Carcinoma, Hepatocellular*
Chemoembolization, Therapeutic
Doxorubicin
Ethiodized Oil*
Humans
Liver Neoplasms
Treatment Outcome

Substances

Antibiotics, Antineoplastic
Ethiodized Oil
Doxorubicin